Novartis Vaccines and Diagnostics

Novartis Products

Vaccines and Diagnostics

The Novartis Vaccines and Diagnostics Division provides more than 20 products to fight vaccine-preventable viral and bacterial diseases. It also creates sophisticated instruments, assays and software to test blood donations for infections.

The division consists of two businesses:

Novartis Vaccines
Novartis Diagnostics, the blood testing business

Visit the Novartis Vaccines Website

Visit the Novartis Diagnostics website

Vaccines

Diagnostics

	PROCLEIX WNV Assay The first Nucleic Acid Testing (NAT) solution approved by the US Food and Drug Administration for qualitative detection of the West Nile virus in RNA plasma specimens from individual donors of blood, organs, cells and tissues

	PROCLEIX HIV-1/HCV Assay Detects HIV and HCV in a single tube, thanks to transcription-mediated amplification (TMA) technology, and was the first NAT solution to be approved for blood screening in the US and to receive the CE Mark in Europe

	PROCLEIX ULTRIO Assay Designed to combine the early detection capabilities of NAT with single-tube TMA technology to deliver simultaneous results for HIV-1, HCV and HBV

Diseases and conditions

Novartis diseases and conditions

Disease education is the first step to a healthier life.

Learn more about diseases and conditions

Vaccines pipeline

Our vaccines development pipeline includes new strategies to protect against flu and meningitis.

Learn about our development pipeline on the Novartis Vaccines website